Literature DB >> 11115160

Detection of type 1 cytokines in discoid lupus erythematosus.

J R Toro1, D Finlay, X Dou, S C Zheng, P E LeBoit, M K Connolly.   

Abstract

BACKGROUND: Although multiple studies suggest a dysregulated T-cell cytokine production in systemic lupus erythematosus, the cytokine profile in discoid lupus erythematosus (DLE) lesions is unknown.
OBJECTIVES: To characterize the cytokine profile in DLE by immunohistochemical and molecular methods, and to investigate the role of cytokines in the pathogenesis of DLE.
DESIGN: Patients were evaluated clinically, and biopsy specimens of lesional skin were examined by light microscopy. Reverse transcriptase-polymerase chain reaction and immunohistochemical analysis were performed on 11 biopsy specimens. We investigated the presence of interleukin (IL) 2, interferon gamma (IFN-gamma), IL-4, tumor necrosis factor alpha, (TNF-alpha), and IL-1beta messenger RNA (mRNA) in 8 biopsy specimens of DLE and compared it with 3 biopsy specimens of normal skin.
SETTING: Academic referral research hospital. PATIENTS: Eight consecutive patients with a clinical and histologic diagnosis of DLE.
RESULTS: Localized DLE was found in 7 patients and widespread in 1. During the 4 years of the investigation, none of the patients developed systemic lupus erythematosus. We found significantly elevated levels of IL-2 and IFN-gamma mRNA in all 8 biopsy specimens of DLE; in contrast, no transcripts of IL-2 or IFN-gamma were detected in 3 biopsy specimens of normal skin (P<.01). Similarly, elevated levels of TNF-alpha mRNA were detected in 8 DLE biopsy specimens, while no TNF-alpha mRNA was detected in 3 biopsy specimens of normal skin (P<.01). No IL-4 or IL-1 beta mRNA was detected in 8 biopsy specimens of DLE lesional skin and 3 biopsy specimens of normal patient skin. Immunohistochemical analysis showed increased staining for IL-2 and IFN-gamma receptors, while no detectable IL-4 receptor was found. No cytokine mRNA or cytokine receptor protein was detected in biopsy specimens of normal skin.
CONCLUSIONS: These findings suggest that DLE is associated with type 1 cytokines characterized by the expression of IL-2 and IFN-gamma. Type 1 cytokines may be critical for induction, development, and maintenance of DLE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115160     DOI: 10.1001/archderm.136.12.1497

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

Review 1.  The pathogenesis of primary cicatricial alopecias.

Authors:  Matthew J Harries; Ralf Paus
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

2.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 3.  Macrophages and the Recovery from Acute and Chronic Inflammation.

Authors:  Kajal Hamidzadeh; Stephen M Christensen; Elizabeth Dalby; Prabha Chandrasekaran; David M Mosser
Journal:  Annu Rev Physiol       Date:  2016-12-07       Impact factor: 19.318

Review 4.  Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases.

Authors:  Leanne M Johnson-Huang; N Scott McNutt; James G Krueger; Michelle A Lowes
Journal:  J Clin Immunol       Date:  2009-02-28       Impact factor: 8.317

5.  Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.

Authors:  Adam S Nabatian; Muhammad M Bashir; Maria Wysocka; Meena Sharma; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2012-01-04       Impact factor: 5.156

6.  IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions.

Authors:  José Ronaldo M Carneiro; Hellen T Fuzii; Cristiane Kayser; Fernando L Alberto; Fernando A Soares; Emília I Sato; Luís Eduardo C Andrade
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.

Authors:  Victoria P Werth; David Fiorentino; Barbara A Sullivan; Michael J Boedigheimer; Kit Chiu; Christine Wang; Gregory E Arnold; Michael A Damore; Jeannette Bigler; Andrew A Welcher; Chris B Russell; David A Martin; James B Chung
Journal:  Arthritis Rheumatol       Date:  2017-03-31       Impact factor: 10.995

8.  Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.

Authors:  Christine Braegelmann; Tanja Fetter; Dennis Niebel; Lara Dietz; Thomas Bieber; Joerg Wenzel
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

9.  Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis.

Authors:  Ali Jabbari; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Juana Gonzalez; Inna Cueto; Andrew G Franks; James G Krueger
Journal:  J Invest Dermatol       Date:  2013-06-14       Impact factor: 8.551

Review 10.  Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.

Authors:  Alicia J Little; Matthew D Vesely
Journal:  Yale J Biol Med       Date:  2020-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.